“tesaro” Archives

in
Entry Author Date Location
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track 06/12/20 National
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs 04/09/20 Boston
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug 10/15/19 Boston
Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More 10/04/19 National
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug 08/23/19 National
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
No Details, But AstraZeneca Touts PARP Drug Win in Pancreatic Cancer 02/26/19 New York
AbbVie Joins Myeloma Race with $90M Deal for Rights to Teneobio Drug 02/11/19 San Francisco
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More 01/07/19 National
Eli Lilly Makes an $8B Cancer Genetics Bet with Loxo Acquisition 01/07/19 Indiana
Ribon Raises $65M to Pursue PARP-Blocking Pills for Cancer 01/04/19 Boston
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
GSK Pays $5.1B For Tesaro, Setting Up “PARP” Battle With Rival AstraZeneca 12/03/18 Boston
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
AstraZeneca’s PARP Drug Is First to Help New Ovarian Cancer Patients 06/27/18 National
Cancer Wrap: Blueprint, Checkmate, More AACR News & Phase 3 Blues 04/18/18 National
Cyteir Bags $29M to Tap “Self Destruct” in Cancers, Immune Diseases 03/08/18 Boston
SpringWorks Spins Out of Pfizer With $103M to Give Shelved Drugs New Life 09/25/17 New York
Last Chance to Save on Boston’s Life Science Disruptors 09/20/17 Boston
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
Catch Dragonfly, IFM, Tesaro at “Disruptors” on Sept. 28 09/05/17 Boston
Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists 08/28/17 Boston
Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists 08/10/17 Boston
Dragonfly, Tyler Jacks Sign On for Boston’s Life Science Disruptors on Sept. 28 08/09/17 Boston
Check Out Tesaro & More at “Disruptors” on Sept. 28; Super Saver Rate Ends Today 08/03/17 Boston
Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps 07/28/17 National
Tesaro Cashes In Again on PARP Blocker With $100M Takeda Deal 07/27/17 Boston
Join Tesaro and Others at Boston’s Life Science Disruptors Sept. 28 07/13/17 Boston
New Ovarian Cancer Data Suggests Larger Role For Top Clovis Drug 06/19/17 Boulder/Denver
Page 1 of 3 next page »